Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

17.79
Delayed Data
As of Jan 20
 -0.26 / -1.44%
Today’s Change
12.25
Today|||52-Week Range
27.02
-1.28%
Year-to-Date
Why Depomed Inc. Stock Spiked Today
Jan 03 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close18.05
Today’s open18.01
Day’s range17.76 - 18.27
Volume1,800,000
Average volume (3 months)1,819,846
Market cap$1.1B
Dividend yield--
Data as of 01/20/2017

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+48.62%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.48

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-0.55-2.55%
TXMDTherapeuticsMD Inc-0.16-2.85%
SGYPSynergy Pharmaceutic...-0.50-7.80%
INVAInnoviva Inc-0.03-0.28%
Data as of 01/20/2017

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)$0.37
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts


Search for Jobs